Applied DNA, a leader in large-scale PCR-based DNA manufacturing, has signed a collaboration agreement with Eurofins BLC to support commercial implementation of Applied DNA’s SigNature T-based leather traceability system. The signing of the agreement follows successful completion of the funded consortium research project with BLC as announced in May 2018.
“We are thrilled to enter into this mutually beneficial relationship with BLC to advance the commercial implementation of our leather tagging system. BLC’s unparalleled knowledge in all aspects of leather processing, long-standing relationships with global brands, and its history of forward-thinking innovation makes them an ideal partner,” Tony Benson, Applied DNA’s managing director with responsibility for Europe, Middle East and Africa (EMEA) said.
“This agreement with BLC significantly enhances our position for the commercial implementation of our leather tagging system. We already have keen interest in the commercial adoption of our system from several project sponsors. We are targeting a defined goal of having 300,000,000 square feet of DNA-tagged leather under contract over the next five years. BLC’s knowledge in the industry and technical expertise will be invaluable to these efforts,” James Hayward president and CEO of Applied DNA said.
“There is a strong need within the leather industry to provide a robust system of traceability for semi-processed and finished leather. This cost-effective application system provides a process for applying a unique molecular tag in a way that is impossible to counterfeit. Eurofins BLC looks forward to supporting our customers in their journey towards supply chain transparency and traceability,” Adam Hughes, managing director of Eurofins BLC leather technology said. (GK)
Fibre2Fashion News Desk – India